ALISO VIEJO, Calif. — February 11, 2026 — Leads & Copy — RxSight, Inc., an ophthalmic medical device company, will release its financial results for the fourth quarter and full year 2025 after market close on Wednesday, February 25, 2026.
Management will discuss the results on a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To join the conference call, dial (800) 715-9871 or (646) 307-1963, and enter conference code 3406720. The call will be broadcast live in listen-only mode via a link on the company’s investor relations website.
An archived recording of the call will be available through the same link shortly after completion.
RxSight, Inc. is focused on providing customized vision to patients after cataract surgery. The RxSight Light Adjustable Lens system includes the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories. It is the only commercially available intraocular lens (IOL) technology that can be adjusted after surgery.
Source: RxSight, Inc.
